| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/11/2001 | EP1090039A1 Peptide composition as immunogen for the treatment of allergy |
| 04/11/2001 | EP1090038A2 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore |
| 04/11/2001 | EP1090037A1 Divalent antibody fragments |
| 04/11/2001 | EP1090033A1 Particles of hcv envelope proteins: use for vaccination |
| 04/11/2001 | EP1089794A2 Methods for inhibiting tef-3 activity |
| 04/11/2001 | EP1089766A2 Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| 04/11/2001 | CN1291233A Human complement (3-degrading proteinase from i (streptococcus pheumoniae) |
| 04/11/2001 | CN1291231A Human telomerase catalytic subunit |
| 04/11/2001 | CN1291107A Skin cave compositions |
| 04/11/2001 | CN1291096A Use of inhibitors for treatment of disorders related to RTK hyperfunction |
| 04/10/2001 | US6214984 Nucleic acid coding for a linear heavy chain fragment including repeating variable and constant domains; recombinant production |
| 04/10/2001 | US6214983 Isolated nucleic acid molecules which encode SCP proteins |
| 04/10/2001 | US6214981 Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof |
| 04/10/2001 | US6214974 Internalizable cell binding component having biotin binding element conjugated to biotinylated nucleic acids or cytotoxic moieties such as gelonin, ricin, saporin, abrin, diptheria toxin and the like; gene therapy; drug delivery of toxins |
| 04/10/2001 | US6214973 Antibody light chain having variable region of defined amino acid sequence and human constant region; antitumor agents; anticarcinogenic agents; diagnosis |
| 04/10/2001 | US6214972 Human receptor of defined amino acid sequence; for recombinant preparation of membranes for screening agonists and antagonists; treatment of sleep disorders, allergic rhinitis, glaucoma, congestive heart failure; antiinflammatory agents |
| 04/10/2001 | US6214970 Hepatitis E virus antigens and uses therefor |
| 04/10/2001 | US6214968 Fibroblast stimulating growth factor 1 (FsF-1) and the early detection of fibrosis |
| 04/10/2001 | US6214613 Has restriction sites to insert sequences which code for variable domains of antibodies in between sequences coding for other domains of antibodies; expresses polypeptides in membrane-bound form on surface of eukaryotic cells |
| 04/10/2001 | US6214600 Polypeptide of defined amino acid sequence; treatment of alzheimer's disease, stroke, musculoskeletal disease, heart disease, kidney disease; anticarcinogenic/antiinflammatory agents; antiarthritic agents; diagnosis |
| 04/10/2001 | US6214595 Enzymatic polypeptide for utilization in screening bactericides; wound healing agents; for prevent of bacterial wound infections |
| 04/10/2001 | US6214588 Polymerase holoenzyme; for use in design drugs that target eukaryotic parasites |
| 04/10/2001 | US6214584 Nucleotide sequence which encodes polypeptide associated with immunocompetence; for use in the treatment and prevent of tumors, viral diseases, bacterial infections and autoimmune diseases |
| 04/10/2001 | US6214580 Nucleotide sequences coding binding protein associated with apoptosis; for detecting modulators of apoptosis; for treating cancers, sepsis, cachexia, autoimmune and viral diseases, inflammation, nervous system and liver disorders |
| 04/10/2001 | US6214579 Flea leucine aminopeptidase nucleic acid molecules and uses thereof |
| 04/10/2001 | US6214571 Method for inhibiting adenylosuccinate synthetase activity in malignant methylthioadenosine phosphorylase deficient cells |
| 04/10/2001 | US6214568 Monoclonal antibodies of isotype IgG which bind specifically to glutamate decarboxylase, and uses thereof |
| 04/10/2001 | US6214564 Method of identifying modulators of protein tyrosine phosphatase activity |
| 04/10/2001 | US6214543 DNA molecule encoding for cellular uptake of Mycobacterium tuberculosis and uses thereof |
| 04/10/2001 | US6214388 Immunoliposomes that optimize internalization into target cells |
| 04/10/2001 | US6214355 DbpA compositions |
| 04/10/2001 | US6214348 Administering to the mammal a polypeptide comprising seq id no:2 in an amount sufficient to induce an immunological response to produce antibodies to seq id no:2 |
| 04/10/2001 | US6214346 Bactericides |
| 04/10/2001 | US6214345 Lysosomal enzyme-cleavable antitumor drug conjugates |
| 04/10/2001 | US6214344 Hepatocyte growth factor receptor antagonists and uses thereof |
| 04/10/2001 | US6214343 Prevention and treatment of necrotizing enterocolitis |
| 04/10/2001 | US6214342 Method for increasing mean survival times of transplants with LFA-1-specific antibodies |
| 04/10/2001 | US6214341 Percutaneously administering to patient an effective amount of human clostridium difficile toxin-neutralizing polyclonal immune globulin obtained from a human subject immunized with a clostridium difficile toxin or toxoid |
| 04/10/2001 | US6213930 Method of using anti-phospholipase A2 antibodies to enhance growth or improve feed efficiency |
| 04/10/2001 | CA2200855C Radioactive phosphorous labeling of proteins for targeted radiotherapy |
| 04/10/2001 | CA2191858C Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy |
| 04/10/2001 | CA2163151C Humanized and chimeric monoclonal antibodies that recognized epidermal growth factor receptor (egf-r). use diagnostic and therapeutic |
| 04/10/2001 | CA2130436C Cloning and expression of humanized monoclonal antibodies against human interleukin-4 |
| 04/10/2001 | CA2081150C Use of antibody-containing preparations for immunosuppression |
| 04/10/2001 | CA2076901C Kainate-binding, human cns receptors of the eaa2 family |
| 04/10/2001 | CA2074089C Extracellular segments of human e immunoglobulin anchoring peptides and antibodies specific therefor |
| 04/05/2001 | WO2001023893A2 Detection of hla-g |
| 04/05/2001 | WO2001023598A1 41 human secreted proteins |
| 04/05/2001 | WO2001023590A2 22196, a novel human aminopeptidase |
| 04/05/2001 | WO2001023584A1 Human ubiquitin protease |
| 04/05/2001 | WO2001023581A1 Enzyme which cleaves ester groups and which is derived from thermomonospora fusca |
| 04/05/2001 | WO2001023573A1 Human type complementation-determining domain transplanted antibody against ganglioside gd2 and derivative of this antibody |
| 04/05/2001 | WO2001023572A2 Polynucleotides and polypeptides encoded thereby |
| 04/05/2001 | WO2001023571A1 Methods and compositions relating to sodium channel beta1a subunits |
| 04/05/2001 | WO2001023570A2 Methods and compositions relating to sodium channel beta-1a subunits |
| 04/05/2001 | WO2001023565A1 P-glycoproteins from macaca fascicularis and uses thereof |
| 04/05/2001 | WO2001023557A1 Novel polypeptides and genes encoding the same |
| 04/05/2001 | WO2001023556A1 Novel hemopoietin receptor protein, nr12 |
| 04/05/2001 | WO2001023554A1 The prv-1 gene and use thereof |
| 04/05/2001 | WO2001023552A1 Human paralogue of a head trauma induced cytoplasmatic calcium binding protein |
| 04/05/2001 | WO2001023551A1 Novel nicotinic acetylcholine receptor subunit, its isolation and use |
| 04/05/2001 | WO2001023550A2 Pca3 messenger rna species in benign and malignant prostate tissues |
| 04/05/2001 | WO2001023547A1 26 human secreted proteins |
| 04/05/2001 | WO2001023546A1 37 human secreted proteins |
| 04/05/2001 | WO2001023543A1 Creation of variable length and sequence linker regions for dual-domain or multi-domain molecules |
| 04/05/2001 | WO2001023540A2 P-glycoproteins and uses thereof |
| 04/05/2001 | WO2001023432A1 Human type complementarity determining region transplantation antibody against ganglioside gd3 and derivatives of antibody against ganglioside gd3 |
| 04/05/2001 | WO2001023431A1 Derivatives of antibody against ganglioside gm2 |
| 04/05/2001 | WO2001023429A1 Immunointeractive molecules and their uses in treating subjects suffering from hev b 5 allergies |
| 04/05/2001 | WO2001023428A2 Interleukin-2 receptor associated polypeptides |
| 04/05/2001 | WO2001023425A1 Factors having prion-binding activity in serum and plasma and agents to detect transmissible spongiform encephalopathitis |
| 04/05/2001 | WO2001023424A1 A phosphatidylethanolamine binding protein (pebp-2) and uses thereof |
| 04/05/2001 | WO2001023416A2 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof |
| 04/05/2001 | WO2001023409A2 38 human secreted proteins |
| 04/05/2001 | WO2001023402A1 43 human secreted proteins |
| 04/05/2001 | WO2001022996A1 Administration of gamma globulins to treat lymphoma |
| 04/05/2001 | WO2001022994A2 Vaccines against neisseria infection |
| 04/05/2001 | WO2001022988A1 ESTROGEN RELATED RECEPTOR, ERRα, A REGULATOR OF BONE FORMATION |
| 04/05/2001 | WO2001022922A2 Engineering antibodies that bind irreversibly |
| 04/05/2001 | WO2001022916A2 Novel hev antigenic peptide and methods |
| 04/05/2001 | WO2001022816A1 MODULATION OF ηδ T CELLS TO REGULATE AIRWAY HYPERRESPONSIVENESS |
| 04/05/2001 | WO2001011369A8 Cancer treatments and diagnostics utilizing rad51 related molecules and methods |
| 04/05/2001 | WO2001006015A8 NOVEL GLYCOSYL SULFOTRANSFERASES GST-4α, GST-4β, AND GST-6 |
| 04/05/2001 | WO2000073450A3 Cytoskeleton-associated proteins |
| 04/05/2001 | WO2000073334A3 Human sorting nexins |
| 04/05/2001 | WO2000071573A3 Immunogenic peptides derived from mage and the use thereof |
| 04/05/2001 | WO2000069914A3 Humanized antibodies specific for egp-2 |
| 04/05/2001 | WO2000068420A3 Identification of candida albicans essential fungal specific genes and use thereof in antifungal drug discovery |
| 04/05/2001 | WO2000065027A3 Human gil-19/ae289 proteins and polynucleotides encoding same |
| 04/05/2001 | WO2000064474A8 Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 04/05/2001 | WO2000056891A3 Human transmembrane proteins |
| 04/05/2001 | WO2000029578A9 Cloning and characterization of two m-rna transcription factors |
| 04/05/2001 | WO2000020450A9 Calcium channel alpha-2/delta gene |
| 04/05/2001 | DE19947010A1 Das Gen PRV-1 und dessen Verwendung The PRV-1 gene and its use |
| 04/05/2001 | DE19944994C1 Aus der Zellinie 2.4G2 abstammende Zellinie, die keine Maus-kappa-Ketten produziert From the cell line 2.4G2 derived cell line which produces a mouse kappa chain |
| 04/05/2001 | CA2387702A1 The prv-1 gene and use thereof |
| 04/05/2001 | CA2386346A1 Novel polynucleotides and polypeptides encoded thereby |
| 04/05/2001 | CA2386197A1 Complementarity determining region-grafted antibody against ganglioside gd3 and derivative of antibody against ganglioside gd3 |
| 04/05/2001 | CA2386077A1 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof |
| 04/05/2001 | CA2386064A1 Estrogen related receptor, err.alpha., a regulator of bone formation |